title: Translation issues in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
authors.affiliation: Division of Neurology, Vancouver Hospital, British Columbia, Canada.
authors.forename: H
authors.initials: H
authors.lastname: Feldman
authors.forename: R
authors.initials: R
authors.lastname: Anand
authors.forename: R
authors.initials: R
authors.lastname: Blesa
authors.forename: B
authors.initials: B
authors.lastname: Dubois
authors.forename: J
authors.initials: J
authors.lastname: Gray
authors.forename: A
authors.initials: A
authors.lastname: Homma
authors.forename: E
authors.initials: E
authors.lastname: Mohr
authors.forename: J C
authors.initials: JC
authors.lastname: Morris
authors.forename: W
authors.initials: W
authors.lastname: Parys
authors.forename: A
authors.initials: A
authors.lastname: Raschig
authors.forename: A
authors.initials: A
authors.lastname: Robillard
mesh_terms: D000368:Aged; D000544:Alzheimer Disease / Q000175:diagnosis / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D003704:Dementia / Q000175:diagnosis / Q000188:drug therapy*; D015507:Drugs, Investigational / Q000627:therapeutic use*; D015577:Geriatric Assessment; D006801:Humans; D007391:International Cooperation; D007802:Language; D009483:Neuropsychological Tests; D018697:Nootropic Agents / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic; D014175:Translating
chemical_list: D015507:Drugs, Investigational; D018697:Nootropic Agents